Horn Howard
SEC CIK 1786335 · EDGAR
BoughtSold
Most active insiders at RARE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Horn Howard | CFO | — | $1.33M |
| 2 | KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| 3 | Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| 4 | Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| 5 | Pinion John Richard | See Remarks | — | $228.7K |
| 6 | Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| 7 | SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| 8 | Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| 9 | Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| 10 | Ray Amrit | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-04 15:13 | 2026-08-03 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $24.92 | -4,696 | 96.3K | -5% | -$117.0K |
| T | 2026-07-06 15:37 | 2026-07-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $33.13 | -4,698 | 101.0K | -4% | -$155.6K |
| T | 2026-06-01 19:11 | 2026-06-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $23.77 | -4,653 | 105.7K | -4% | -$110.6K |
| T | 2026-05-04 17:35 | 2026-05-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $24.90 | -4,683 | 110.3K | -4% | -$116.6K |
| D | 2026-04-20 17:09 | 2026-04-16 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | A - Grant | $0.00 | +34.7K | 115.0K | +43% | $0 |
| T | 2026-04-02 18:19 | 2026-04-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $20.97 | -4,683 | 80.4K | -6% | -$98.2K |
| MT | 2026-03-03 | 2026-03-02+ | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $22.65 | -10.0K | 86.7K | -10% | -$227.5K |
| T | 2026-03-03 | 2026-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | A - Grant | $0.00 | +6,143 | 95.1K | +7% | $0 |
| T | 2026-02-03 | 2026-02-02 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $23.56 | -3,061 | 88.9K | -3% | -$72.1K |
| T | 2026-01-05 | 2026-01-02 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $22.84 | -3,150 | 92.0K | -3% | -$71.9K |
| T | 2025-12-11 | 2025-12-10 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $36.38 | -3,081 | 95.1K | -3% | -$112.1K |
| 2025-10-14 | 2025-10-13 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $31.51 | -7,942 | 98.2K | -7% | -$250.3K | |
| 2025-03-10 | 2025-03-06 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $40.40 | -1,785 | 106.2K | -2% | -$72.1K | |
| D | 2025-03-04 | 2025-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | A - Grant | $0.00 | +15.7K | 108.0K | +17% | $0 |
| 2024-10-11 | 2024-10-10 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | S - Sale | $52.76 | -7,465 | 92.3K | -7% | -$393.9K | |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | A - Grant | $0.00 | +19.4K | 99.8K | +24% | $0 |
| D | 2023-10-10 | 2023-10-09 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | CFO | A - Grant | $0.00 | +80.4K | 80.3K | New | $0 |
| 2023-02-24 | 2023-02-23 | VIR | Vir Biotechnology, Inc. | Horn Howard | CFO | S - Sale | $25.97 | -2,248 | 230.7K | -1.0% | -$58.4K | |
| 2023-02-21 | 2023-02-17 | VIR | Vir Biotechnology, Inc. | Horn Howard | CFO | S - Sale | $25.29 | -2,424 | 233.0K | -1% | -$61.3K | |
| D | 2022-02-24 | 2022-02-22 | VIR | Vir Biotechnology, Inc. | Horn Howard | CFO | A - Grant | $0.00 | +35.0K | 235.4K | +17% | $0 |
| 2022-02-22 | 2022-02-17 | VIR | Vir Biotechnology, Inc. | Horn Howard | CFO | S - Sale | $31.93 | -2,393 | 200.4K | -1% | -$76.4K |
Purchase Sale Sale after option exercise All abbreviations